Dr. Maissaa Janbain was born in Beirut, Lebanon, and graduated from Lebanese University School of Medicine in 2005. She moved to Cleveland, Ohio to complete her training in Internal Medicine, graduated from Case Western Reserve University in 2009 and continued her medical training at Tulane School of Medicine as a hematologist/oncologist. In 2015, she joined the LCBCD as Assistant Professor of Clinical Medicine.

Currently, she serves as the Associate Director of the LCBCD. In addition to seeing patients with hemophilia, von Willebrand Disease and blood clotting disorders, she runs a woman’s clinic dedicated to providing comprehensive care to our girls and young women with bleeding and clotting disorders. Dr. Janbain has received several awards and grants and is active in research focusing on the use of global assays as biomarkers of outcomes in hematologic disorders.

She has presented her work at national and international conferences, including the use of tranexamic acid as adjunctive therapy to prophylaxis in patients with hemophilia, and the use of aspirin in aging patients with hemophilia.